K
KALA BIO, Inc. (KALA)
NCM – Real Time Price. Currency in USD
0.18
-0.02 (-12.15%)
At close: Mar 27, 2026, 4:00 PM EDT
0.17
-0.00 (-0.97%)
After-hours: Mar 27, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
0.18
-0.02 (-12.15%)
At close: Mar 27, 2026, 4:00 PM EDT
0.17
-0.00 (-0.97%)
After-hours: Mar 27, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.75 | 6.05 | 4.0 | |
| Quick ratio | 0.75 | 5.63 | 4.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 1.20 | 1.04 | 1.0 | |
| Interest coverage | -11.07 | -16.91 | 1.0 | |
| Weighted average score | 2.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 11M | 4M | N/A | N/A | N/A |
| Gross Profit | 7M | 1M | -303K | -259K | -332K |
| Operating Income | -109M | -81M | -39M | -40M | -42M |
| Net Income | -143M | -45M | -42M | -39M | -36M |
| EBITDA | -107M | -80M | -39M | -40M | -41M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 81.61 | 5.5 |
| Next quarter | N/A | 87.94 | 5.5 |
| Current year | N/A | 56.16 | 5.5 |
| Next year | N/A | 88.09 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 32.19 | N/A | -40.33 | 5.5 |
| Y/Y | 999 | 15.49 | N/A | -125.87 | 5.3 |
| 3y average | 277.88 | 27.72 | 51.91 | 29.23 | 10 |
| 5y average | 183.01 | 7.18 | 34.72 | 14.28 | 8.3 |
| Weighted average score | 7.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $29.9M significantly exceeds cash reserves ($21.1M), raising financial stability concerns
Total current liabilities $32.6M surpass Total current assets $24.3M, signaling liquidity issues
Debt-to-equity ratio (-3.5) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-11.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$10.9M limits the company's ability to reinvest or pay down debt